Coverage
-
February 18, 2025
After being ordered by the Federal Circuit to reconsider its decision upholding some claims of an Omni MedSci Inc. heart rate monitor patent challenged by Apple Inc., the Patent Trial and Appeal Board has found all the claims of the patent invalid as obvious.
2 other articles on this case.
View all »